Sec Form 4 Filing - ROOT JONATHAN D @ Omada Health, Inc. - 2025-06-05

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person ROOT JONATHAN D 2. Issuer Name and Ticker or Trading Symbol Omada Health, Inc. [ OMDA] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O OMADA HEALTH, INC., 500 SANSOME STREET, SUITE 200 3. Date of Earliest Transaction (MM/DD/YY) 06/05/2025 (Street) SAN FRANCISCO, CA94111 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 06/05/2025 A 9,736 ( 1 ) A $ 0 9,736 D Common Stock 06/09/2025 C 4,539,436 A 4,571,769 I See footnotes ( 3 ) ( 5 ) Common Stock 06/09/2025 C 145,223 A 146,257 I See footnotes ( 4 ) ( 5 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series A Preferred Stock ( 2 ) 06/09/2025 C 1,813,927 ( 2 ) ( 2 ) Common Stock 1,813,927 ( 2 ) 0 I See footnotes ( 3 ) ( 5 ) Series B Preferred Stock ( 2 ) 06/09/2025 C 1,775,025 ( 2 ) ( 2 ) Common Stock 1,775,025 ( 2 ) 0 I See footnotes ( 3 ) ( 5 ) Series C Preferred Stock ( 2 ) 06/09/2025 C 357,402 ( 2 ) ( 2 ) Common Stock 357,402 ( 2 ) 0 I See footnotes ( 3 ) ( 5 ) Series C-1 Preferred Stock ( 2 ) 06/09/2025 C 258,931 ( 2 ) ( 2 ) Common Stock 258,931 ( 2 ) 0 I See footnotes ( 3 ) ( 5 ) Series D Preferred Stock ( 2 ) 06/09/2025 C 334,151 ( 2 ) ( 2 ) Common Stock 334,151 ( 2 ) 0 I See footnotes ( 3 ) ( 5 ) Series A Preferred Stock ( 2 ) 06/09/2025 C 58,030 ( 2 ) ( 2 ) Common Stock 58,030 ( 2 ) 0 I See footnotes ( 4 ) ( 5 ) Series B Preferred Stock ( 2 ) 06/09/2025 C 56,786 ( 2 ) ( 2 ) Common Stock 56,786 ( 2 ) 0 I See footnotes ( 4 ) ( 5 ) Series C Preferred Stock ( 2 ) 06/09/2025 C 11,434 ( 2 ) ( 2 ) Common Stock 11,434 ( 2 ) 0 I See footnotes ( 4 ) ( 5 ) Series C-1 Preferred Stock ( 2 ) 06/09/2025 C 8,283 ( 2 ) ( 2 ) Common Stock 8,283 ( 2 ) 0 I See footnotes ( 4 ) ( 5 ) Series D Preferred Stock ( 2 ) 06/09/2025 C 10,690 ( 2 ) ( 2 ) Common Stock 10,690 ( 2 ) 0 I See footnotes ( 4 ) ( 5 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other ROOT JONATHAN D C/O OMADA HEALTH, INC. 500 SANSOME STREET, SUITE 200 SAN FRANCISCO, CA94111 X Signatures /s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root 06/09/2025 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the first anniversary of June 5, 2025. ( 2 )Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date. ( 3 )Shares held by U.S. Venture Partners X, L.P. ( 4 )Shares held by USVP X Affiliates, L.P. ( 5 )Presidio Management Group X, L.L.C. ("PMG X"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.